NeuroDawn Pharmaceutical
Jiangning
About NeuroDawn Pharmaceutical
NeuroDawn Pharmaceutical develops new drugs that are designed to treat central nervous system diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $53.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2024)
- Website: neurodawn.cn
- Phone: +86 025 58835098
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical
Canonical: https://fsome.com/organization/neurodawn-pharmaceutical-63328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.